Japan Sets New Reimbursement Prices For NHI-qualified Drugs; Cuts Average 5.75 Percent
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan's Ministry of Health, Labor and Welfare March 5 posted new reimbursement prices of National Health Insurance-qualified drugs, the first such change in two years. The new prices are effective April 1
You may also be interested in...
Japan's Chuikyo To Weigh In On New Drug Pricing Program
An experimental drug pricing policy to shelter selected new drugs from price cuts will be high on the agenda for Japan's reimbursement body, the Central Social Medical Insurance Agency, for the coming year, according to the agency's just-released schedule for hearings and discussions for 2011
Japan's Chuikyo To Weigh In On New Drug Pricing Program
An experimental drug pricing policy to shelter selected new drugs from price cuts will be high on the agenda for Japan's reimbursement body, the Central Social Medical Insurance Agency, for the coming year, according to the agency's just-released schedule for hearings and discussions for 2011
Japan To Lower Price Of Eight Drugs From Takeda, Novartis, BMS And Chugai By 12-18 Percent
As part of an ongoing re-pricing policy for drugs that have seen expanded market share, Japan's Ministry of Health, Labor and Welfare has decided to lower the price on eight drugs effective April 1